SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ROTC:Rotech medical

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Etana Finkler who wrote (102)7/10/1997 7:30:00 PM
From: jeff @crown   of 161
 
Hello

I did the same thing as you... went to the library and checked the expanded edition. Here's what I found (summarized)

Performance 1
Technical 3
Safety 4

Financial Strength C++
Price Stability 15
Price Growth Persistance 30
Earnings Predictability 85

EPS
94 1.71
95 2.39
96 1.46 (D .26 3rd Quarter)
97 .72 1st Quarter only

Sales
94 683 $Mil
95 1139
96 1389
97 461 1st Quarter

Common Stock 24,748,680 (35% of Capital)
Debt 1097 $Mil (65% of Capital)

Market Capitalization is listed in the top 10-15 (highest)listings in the expanded edition.

I have more if you are interested in something specific.

I'm also puzzled by the markets reaction to this deal... IHS stock is down over 5 points since the announcement carrying me down with it.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext